Carvalho, D.M.; Nardotto, G.H.B.; Filgueira, G.C.d.O.; Duarte, G.; Cavalli, R.C.; Lanchote, V.L.; Moisés, E.C.D.
Gestational Diabetes Mellitus Does Not Change the Pharmacokinetics and Transplacental Distribution of Fluoxetine and Norfluoxetine Enantiomers. Pharmaceutics 2025, 17, 35.
https://doi.org/10.3390/pharmaceutics17010035
AMA Style
Carvalho DM, Nardotto GHB, Filgueira GCdO, Duarte G, Cavalli RC, Lanchote VL, Moisés ECD.
Gestational Diabetes Mellitus Does Not Change the Pharmacokinetics and Transplacental Distribution of Fluoxetine and Norfluoxetine Enantiomers. Pharmaceutics. 2025; 17(1):35.
https://doi.org/10.3390/pharmaceutics17010035
Chicago/Turabian Style
Carvalho, Daniela Miarelli, Glauco Henrique Balthazar Nardotto, Gabriela Campos de Oliveira Filgueira, Geraldo Duarte, Ricardo Carvalho Cavalli, Vera Lucia Lanchote, and Elaine Christine Dantas Moisés.
2025. "Gestational Diabetes Mellitus Does Not Change the Pharmacokinetics and Transplacental Distribution of Fluoxetine and Norfluoxetine Enantiomers" Pharmaceutics 17, no. 1: 35.
https://doi.org/10.3390/pharmaceutics17010035
APA Style
Carvalho, D. M., Nardotto, G. H. B., Filgueira, G. C. d. O., Duarte, G., Cavalli, R. C., Lanchote, V. L., & Moisés, E. C. D.
(2025). Gestational Diabetes Mellitus Does Not Change the Pharmacokinetics and Transplacental Distribution of Fluoxetine and Norfluoxetine Enantiomers. Pharmaceutics, 17(1), 35.
https://doi.org/10.3390/pharmaceutics17010035